Case Study
Crystallizing knowledge of an in‑licensed product for strategic alignment.
Inflection Point
Our client was preparing for a fast-approaching launch of a recently in-licensed product. As a second-line treatment for a rare disease, the treatment pathway was complex and not well-understood. The newly-formed team needed to align on the most critical opportunities and barriers and in order to make strategic choices ahead of launch.
How We Helped
We conducted an in-depth current state analysis, distilling internal documentation and academic literature to map the path to treatment. The path to treatment featured epidemiological data, healthcare provider decision points, and patient experience insights.
In a 2-day hands-on working session with the cross-functional leadership team, we facilitated feedback on the treatment pathway, identified gaps and key opportunity areas, and aligned on strategic imperatives for the upcoming launch.
After the workshop, we finalized the topline path to treatment, a functional- planning template, and strategic imperatives. Later, we refined the details of the path to treatment so it could be used for onboarding the field team ahead of launch.
As a leadership team, we didn’t have a single source of truth to align decision-making. Workomics created clarity from disparate data, and allowed each team to move forward with a clear understanding of what was most critical for launch success.
— Leadership Team Member
Outcomes
The planning templates we created were immediately used by cross-functional leaders as part of their tactical planning for launch. The treatment pathway became the foundation of an engaging onboarding module that reinforced the organization’s commitment to patient centricity. Ultimately, this work enabled our client to have important strategic conversations on a compressed timeline, while establishing a foundation for long-term strategic alignment.
